CASI Pharma (CASI) Misses Q3 EPS by 67c
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.
CASI Pharma (NASDAQ: CASI) reported Q3 EPS of ($0.67). Revenue for the quarter came in at $3.07 million.
For earnings history and earnings-related data on CASI Pharma (CASI) click here.